California Table Grape Commission
11
5
6
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Anthocyanin-Rich Table Grape Powder for Prophylaxis of Post-Operative Atrial Fibrillation
Role: collaborator
Prebiotic Effects of California Grapes on Gut Health and Cardiometabolic Health in Overweight Men and Women
Role: collaborator
Effect of Grapes in Inflammatory Bowel Disease
Role: collaborator
Effects of Grape Powder on Psychological Distress and Gut Microbiota in College Students
Role: collaborator
Effects of Grape Consumption on the Immune-Gut Axis in Obesity
Role: collaborator
De-stressing the Brain: Can Eating Grapes During Periods of Mental Stress Protect Brain and Vascular Health in Young Adults
Role: collaborator
Impact of Grape Powder Consumption on Eye Health and Glycemic Status in Singapore Older Adults
Role: collaborator
The Influence of Daily Grapes Intake on Sarcopenia in Postmenopausal Women
Role: collaborator
Impact of Grape Consumption on Brain Metabolism and Neuropsychological Performance Over 1 Year
Role: collaborator
Grape Polyphenols and Second-meal Effect
Role: collaborator
Effects of a Standardized Freeze-dried Grape Powder on High Density Lipoprotein (HDL) Function in Metabolic Syndrome
Role: collaborator
All 11 trials loaded